3002.90.52.50/Interferon Beta-1a Injection for MS/China

Interferon Beta-1a Injection for MS from China

A recombinant interferon beta-1a formulation for relapsing multiple sclerosis treatment, regulating immune processes. Falls under HTS 3002.90.52.50 as an immunological product (interferon) prepared for therapeutic use via biotechnological methods. It reduces disease activity in neurological conditions.

Duty Rate — China → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Include recombinant DNA origin docs and bioequivalence studies for biologics approval

• Use validated cold chain with temperature excursions monitored for protein integrity

• Specify therapeutic dosing to distinguish from research cytokines

Interferon Beta-1a Injection for MS from China — Import Duty Rate | HTS 3002.90.52.50